Category Archives: Cancer Treatment

Home / Cancer Treatment
2 Posts

Eric Lefkofsky is one of Chicago’s brightest entrepreneurs. Lefkofsky co-founded Tempus labs out of Chicago. The enterprise first opened in 2015, now rated as part of the top ten health tech start-up companies. Tempus is a tech company that constructed an operating system for battling cancer. Tempus works with the majority of National Cancer Institute’s cancer centers in the country. The health company offers a variety of cancer testing, including RNA sequencing of tumors, and immune system characterization of tumors.

Eric Topol recognized Tempus labs on their list in which Dr. Topol looks into technological advances. The company has also been named for the groundbreaking advances in technology. Gene editing and gene therapy are two areas that Tempus labs have advanced. These advances were for diseases that were previously deemed as untreatable.
The US Food and Drug Administration (FDA) approved a treatment for inherited vision loss caused by a specific gene. Stanford University scientist were able to develop a mathematical equation for detecting skin cancer. Two glucose sensors, approved by the FDA, can now give doses of insulin. There are many other advances that have recently been made in the cure for cancer.

Eric Lefkofsky has co-founded several other companies along with Tempus, including Groupon, Lightbank, Uptake Technologies, and several others. Lefkofsky also co-founded Lefkofsky Family Foundation with his wife. The foundation focuses on initiatives in education, human rights, medicine, art and culture. It has a positive impact on communities. Quality education for students and fundamental human rights for underserving communities is just two of the main focuses of the foundation. He serves on several boards and committees. He is the Trustee of Lurie Children’s Hospital as well as The Art Institute of Charlotte. Lefkofsky is also a professor at the University of Chicago, his alma mater. He also wrote ‘Accelerated Disruption: Understanding the True Speed of Innovation.’

Learn More: www.crunchbase.com/person/eric-lefkofsky

Cancer has long been the single most dangerous affliction facing humanity at large. Those that are fortunate enough to survive their battle against cancer still suffer the debilitating symptoms brought upon by the disease itself and the very treatments designed to combat it. Though devastating, cancer is completely an issue that can be solved with the right tools and resources available to the right doctors and specialist.

The doctors of Chicago’s University of Chicago gained such a tool in their fight to better treat those in their care. Tempus, the creation of Groupon founder Eric Lefkofsky, has partnered with the medical establishment and has provided the oncology departments with access to their state of the art data collection and analyzation programs. Tempus will aid doctors by collecting and analyzing data collected from thousands of breast cancer patients to help researchers and doctors find any similarities between the data that can be used to improve treatments.The disease as dangerous as it is, has very little collected data on the patients that battle the disease.

Dr. Olufunmilayo Olopade, Dean for Global Health at the University of Chicago spoke about the lack of usable data in a statement made to press, “This forces too many physicians to make treatment decisions without the benefit of highly specific genetic information that could help them make better informed and precisely targeted decisions.” She continued, “We are excited to partner with Tempus on this initiative and eager to support its efforts to build the largest clinically annotated molecular data set in breast cancer.”The partnership comes on the heels of a string of new partnerships between the tech start-up and other establishments who are embroiled in the fight to end cancer. The start-up that sprung into the scene earlier last year has quickly gone from unknown start-up to leading the charge among tech start-ups in the fight to end cancer.